Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1
Clinical trial NCT04523116 · UNKNOWN
Trial details
- NCT number
- NCT04523116
- Sponsor
- University of Manchester
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-14
- Primary completion
- 2023-05-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.